Literature Index

Exosome Research Publications

A curated index of peer-reviewed literature on biomolecular signaling vesicles across dermatology, orthopedics, hair restoration, EV biology, and neuroprotection research. All summaries are literature descriptions only and do not constitute efficacy claims.

15

Curated Publications

5

Research Areas

2023

Earliest Year

2025

Most Recent

Research Context Only. The following summaries describe published peer-reviewed literature. They do not constitute efficacy claims for ExaVeyra products. ExaVeyra Sciences supplies biomolecular signaling vesicles for topical aesthetic treatments in clinics and for medical, molecular biology, and biochemistry research. All products are supplied to NPI-verified practitioners and licensed investigators.

β—ˆ

Dermatology & Topical Aesthetic

Published studies examining biomolecular signaling vesicles in topical aesthetic applications, photoaging, and post-procedure skin treatments in clinical settings.

[D1]Prospective randomized split-face RCT2023

Adipose-derived MSC exosomes combined with microneedling in facial photoaging

Journal of Cosmetic Dermatology

DOI: 10.1111/jocd.15623

Study design: Prospective randomized split-face RCT, 12 weeks

Key finding: Combination group showed statistically significant improvement vs. saline control in photoaging scores (p = 0.005). Improvements noted in texture, fine lines, and luminosity assessments.

RCTMicroneedlingPhotoagingAdipose MSC
[D2]Review article2023

Exosomes in skin photoaging: molecular mechanisms and clinical opportunity

Cell Communication and Signaling

DOI: 10.1186/s12964-023-01156-9

Study design: Review article

Key finding: Examines EV-mediated modulation of matrix metalloproteinase expression, type I collagen and elastin synthesis pathways, and UV-induced senescence markers. Identifies topical delivery as a practical application vector.

ReviewPhotoagingMMPCollagen
[D3]Prospective comparative study2024

Platelet-rich exosomes versus PRP in facial skin rejuvenation: comparative outcomes

Aesthetic Surgery Journal

Study design: Prospective comparative study

Key finding: Platelet-derived EVs demonstrated comparable improvement in global aesthetic improvement scale scores to PRP at 12 weeks, with a favorable tolerability profile in practitioner-assessed outcomes.

ComparativePRPAestheticPlatelet EV
[D4]In vitro + preclinical2023

Small extracellular vesicles from human adipose tissue in wound microenvironment modulation

Frontiers in Bioengineering and Biotechnology

DOI: 10.3389/fbioe.2023.1140116

Study design: In vitro + preclinical

Key finding: Adipose-derived small EVs modulated keratinocyte and fibroblast behavior in controlled in vitro assays. Preclinical data supports further clinical investigation in post-procedure recovery contexts.

PreclinicalAdiposeFibroblastKeratinocyte
β—‰

Orthopedics & Musculoskeletal

Clinical trials and mechanistic research on MSC-derived extracellular vesicles in joint, cartilage, and tendon research contexts.

[O1]Triple-blind2024

Placental MSC-derived EVs in knee osteoarthritis: triple-blind placebo-controlled trial

BMC Musculoskeletal Disorders

DOI: 10.1186/s12891-024-07321-z

Study design: Triple-blind, randomized, placebo-controlled RCT

Key finding: Intra-articular placental MSC-derived EV administration evaluated at 2 and 6 months post-injection. Primary endpoints: VAS pain scale, WOMAC functional score, MRI cartilage grading. Study represents one of the most rigorous EV trial designs published to date.

RCTKnee OAPlacental MSCIntra-articular
[O2]Phase 1 dose-escalation2024

UC-MSC exosomes in knee OA: Phase 1 dose-escalation trial (NCT06431152)

ClinicalTrials.gov

Study design: Phase 1 dose-escalation, ongoing

Key finding: Umbilical cord MSC-derived exosomes under active Phase 1 investigation. Dose-escalation design evaluating safety and tolerability of intra-articular administration across three cohorts.

Phase 1UC-MSCDose EscalationOngoing
[O3]Systematic review + preclinical2023

MSC-derived extracellular vesicles in tendinopathy: mechanisms and preclinical evidence

Stem Cell Research and Therapy

DOI: 10.1186/s13287-023-03312-3

Study design: Systematic review + preclinical

Key finding: Reviews MSC-EV effects on tenocyte proliferation, revascularization signaling, and intracellular repair pathways in tendon injury models. Identifies miRNA cargo as a key mediator of downstream effects.

ReviewTendinopathyTenocytemiRNA
β—Œ

Hair Restoration & Trichology

Research on biomolecular signaling vesicles in androgenetic alopecia, dermal papilla signaling, and comparative trials against established hair restoration modalities.

[H1]Prospective observational study2024

Exosome applications in androgenetic alopecia: prospective clinical evaluation

Aesthetic Plastic Surgery

DOI: 10.1007/s00266-024-04332-3

Study design: Prospective observational study

Key finding: Scalp-applied exosome protocols evaluated over 24 weeks. Hair density, shaft diameter, and terminal-to-vellus ratio used as primary outcome measures. Results support further controlled investigation.

ProspectiveAGAHair DensityTopical
[H2]Randomized comparative trial2024

Exosomes versus platelet-rich plasma in hair restoration: active comparative trial (NCT06239207)

ClinicalTrials.gov

Study design: Randomized comparative trial, ongoing

Key finding: Head-to-head trial comparing exosome applications directly against PRP injections in androgenetic alopecia. Primary completion estimated 2025. Represents the first powered comparative trial of this type.

RCTvs PRPAGAOngoing
[H3]Systematic review2025

Extracellular vesicles and hair follicle biology: systematic review across alopecia types

Clinical, Cosmetic and Investigational Dermatology

DOI: 10.2147/CCID.S543451

Study design: Systematic review

Key finding: Synthesizes evidence across androgenetic alopecia, alopecia areata, and chemotherapy-induced alopecia. Identifies dermal papilla cell signaling and Wnt pathway modulation as primary proposed mechanisms across sources.

Systematic ReviewWnt PathwayDermal Papilla2025
⬑

EV Biology & Mechanisms

Foundational and translational research on extracellular vesicle biogenesis, cargo composition, biodistribution, and delivery mechanisms relevant to clinical research applications.

[E1]RCT2025

Wharton's jelly MSC-derived EVs in diabetic foot: randomized controlled trial

Stem Cell Research and Therapy

DOI: 10.1186/s13287-025-04082-x

Study design: RCT, 4-week topical application protocol

Key finding: One of the first RCTs evaluating topically applied Wharton's jelly MSC-derived EVs in a clinical population. Evaluated at 2 and 4 weeks using standardized wound assessment criteria and biomarker panels.

RCTWharton's JellyMSC-EVTopical
[E2]Phase 12023

First-in-human trial of allogeneic platelet-derived extracellular vesicles

Journal of Clinical Investigation

DOI: 10.1172/JCI169973

Study design: Phase 1, first-in-human safety trial

Key finding: Evaluated safety, tolerability, and pharmacokinetics of allogeneic platelet-derived EVs in a first-in-human design. No dose-limiting toxicities observed at evaluated dose levels. Established foundational safety data for platelet EV clinical development.

Phase 1First-in-HumanPlatelet EVSafety
[E3]International Society for Extracellular Vesicles consensus guidelines2024

Minimal information for studies of extracellular vesicles (MISEV2023)

Journal of Extracellular Vesicles

DOI: 10.1002/jev2.12404

Study design: International Society for Extracellular Vesicles consensus guidelines

Key finding: Updated ISEV standards for EV characterization, reporting, and functional assays. Establishes criteria for nanoparticle tracking analysis, electron microscopy, surface marker validation, and cargo quantification that govern cGMP EV manufacturing.

GuidelinesISEVcGMPCharacterization
β—Ž

Neuroprotection & CNS Research

Preclinical and early translational research on MSC-derived extracellular vesicles in neuroinflammation, CNS signaling, and blood-brain barrier dynamics.

[N1]Narrative review2024

MSC-derived extracellular vesicles as cell-free strategy in TBI: 2024 review

Neural Regeneration Research

DOI: 10.4103/1673-5374.374143

Study design: Narrative review

Key finding: Reviews preclinical evidence for MSC-EV traversal of the blood-brain barrier via nano-scale vesicle properties. Discusses neuroinflammation modulation, glial activation suppression, and axonal signaling in TBI models. Identifies key open questions for IND-track development.

ReviewTBIBlood-Brain BarrierMSC-EV
[N2]Preclinical rodent model2023

Glial progenitor cell-derived EVs and miRNA modulation in rodent TBI model

Scientific Reports

DOI: 10.1038/s41598-023-47627-2

Study design: Preclinical rodent model

Key finding: Glial progenitor-derived EVs delivered intranasally modulated miR-21 and miR-146a expression in peri-lesional cortex. Findings suggest EV-mediated miRNA transfer as a mechanism for neuroinflammatory regulation post-injury.

PreclinicalmiRNAGlialIntranasal
Science Foundation

Grounded in Peer-Reviewed Science

Every ExaVeyra product category is supported by independently published, open-access research from PubMed, Nature, and the National Library of Medicine.

11
Peer-Reviewed Publications
90+
Clinical Exosome Trials Analyzed
153K
Patient Cohort GLP-1 Data
β—ˆ PubMed Β· PMC Β· Nature Group